The BalancedInvestor Club

Biotechnology Industry Analysis

717 companies analyzed • Returns from -664.4% to +591.6%

Company List (719 Results)

View:
Sort:

Industry Performance

(717/717 companies)
2025-07-22 → 2026-07-20
Weighted Avg
+25.6%
Best
+591.6%
Worst
-664.4%
Returns Distribution
Top 5
1. SPRB+591.6%2. PTNT+493.4%3. CUBT+463.6%4. MRSN+438.1%5. CUE+353.9%
Bottom 5
1. CERO-664.4%2. ADTX-620.7%3. LEXXW-482.3%4. CARM-430.6%5. BCTXW-426.4%

SPRB

+591.6%

Spruce Biosciences Inc

PTNT

+493.4%

Internet Patents Corp

CUBT

+463.6%

Curative Biotechnology Inc

MRSN

+438.1%

Mersana Therapeutics Inc

CUE

+353.9%

Cue Biopharma

RLYB

+353.3%

Rallybio Corp

RVMDW

+350.2%

Revolution Medicines, Inc. Warrant

GNPX

+329.6%

Genprex Inc

STRO

+327.2%

Sutro Biopharma

NCNA

+320.8%

NuCana PLC

PMN

+291.2%

ProMIS Neurosciences Inc.

ATHA

+286.8%

Athira Pharma Inc

ASBP

+282.5%

Aspire BioPharma, Inc.

LONA

+278.5%

Athira Pharma Inc

IMUX

+277.4%

Immunic Inc

INTS

+272.9%

Intensity Therapeutics, Inc. Common stock

DRTSW

+269.3%

Alpha Tau Medical Ltd. Warrant

ABVX

+257.6%

Abivax SA American Depositary Shares

XLO

+250.5%

Xilio Development Inc

ERAS

+241.6%

Erasca Inc

1–20 of 719
Page 1 of 36
Methodology

The Weighted Average return (+25.6%) is calculated using market capitalization as weights. This gives larger companies more influence on the average, providing a more market-representative view.

669 companies with market cap data included: SPRB, CUBT, MRSN, CUE, RLYB, GNPX, STRO, NCNA, PMN, ATHA and 659 more...

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer